Conference Review

Vit-Buckle Society’s tips for challenging retina cases

A roundup of this year’s standout talks highlights surgical and teaching pearls.

Studies on CRA message for CRAO, ranibizumab biosimilar switch and in-office pneumatic retinopexy also highlighted ASRS 2024.

Four ASRS abstracts look at ANX007, pegcetacoplan, encapsulated cell therapy and tarcocimab.

Also from the Angiogenesis, Exudation, and Degeneration meeting, emerging treatments for nAMD and MacTel2, and a marker for anti-VEGF success in ROP.

Standout Retina Subspecialty Day 2022 talks include real-world faricimab and high-dose aflibercept results, and Protocol T outcomes.

Prime cuts from ASRS also include a quick-response program for CRAO, and trials of agents for GA and mydriasis reversal.